Total number of publications: 37
2022
-
Guanine quadruplexes in the RNA genome of the tick-borne encephalitis virus: their role as a new antiviral target and in virus biology
Nucleic Acids Research, year: 2022, volume: 50, edition: 8, DOI
-
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
EBioMedicine, year: 2022, volume: 76, edition: February, DOI
-
Porphyrins as potent inhibitors of the entry process of tick-borne encephalitis virus
Year: 2022, type: Conference abstract
2021
-
Broad-Spectrum Antiviral Activity of 3'-Deoxy-3'Fluoroadenosine against Emerging Flaviviruses
Antimicrobial Agents and Chemotherapy, year: 2021, volume: 65, edition: 2, DOI
-
Porphyrins and metalloporphyrins as potent inhibitors of the entry process of tick-borne encephalitis virus
Year: 2021, type: Conference abstract
2020
-
FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells
Microorganisms, year: 2020, volume: 8, edition: 4, DOI
-
Tick-Borne Encephalitis Virus Vaccines Contain Non-Structural Protein 1 Antigen and may Elicit NS1-Specific Antibody Responses in Vaccinated Individuals
Vaccines, year: 2020, volume: 8, edition: 1, DOI
2019
-
An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice
JOURNAL OF VIROLOGY, year: 2019, DOI
-
Viral RNA-dependent RNA polymerase inhibitor 7-deaza-2'-C-methyladenosine prevents death in a mouse model of West Nile virus infection
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, year: 2019, volume: 63, edition: 3, DOI